Mettler-Toledo International’s (MTD) “Underperform” Rating Reaffirmed at Jefferies Financial Group

Jefferies Financial Group reaffirmed their underperform rating on shares of Mettler-Toledo International (NYSE:MTDFree Report) in a research note issued to investors on Monday, MarketBeat Ratings reports. The brokerage currently has a $1,250.00 price target on the medical instruments supplier’s stock, up from their prior price target of $1,230.00.

A number of other research firms have also recently issued reports on MTD. Robert W. Baird lifted their target price on Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the company a neutral rating in a research report on Monday, May 13th. StockNews.com upgraded shares of Mettler-Toledo International from a hold rating to a buy rating in a research report on Monday, April 29th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the stock an in-line rating in a research report on Thursday, April 4th. Citigroup upped their target price on Mettler-Toledo International from $975.00 to $1,200.00 and gave the stock a sell rating in a report on Monday, May 13th. Finally, Stifel Nicolaus lifted their price target on Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the company a buy rating in a research note on Monday, May 13th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International presently has a consensus rating of Hold and an average target price of $1,256.25.

View Our Latest Stock Report on MTD

Mettler-Toledo International Stock Down 0.3 %

MTD opened at $1,399.43 on Monday. Mettler-Toledo International has a twelve month low of $928.49 and a twelve month high of $1,535.86. The stock has a market capitalization of $29.89 billion, a price-to-earnings ratio of 39.24, a P/E/G ratio of 3.77 and a beta of 1.20. The company has a 50-day simple moving average of $1,339.95 and a 200 day simple moving average of $1,246.96.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share for the quarter, topping analysts’ consensus estimates of $7.61 by $1.28. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. The company had revenue of $925.95 million during the quarter, compared to the consensus estimate of $879.72 million. During the same quarter in the prior year, the firm posted $8.69 EPS. The firm’s quarterly revenue was down .3% on a year-over-year basis. Sell-side analysts anticipate that Mettler-Toledo International will post 40.09 EPS for the current fiscal year.

Insider Activity

In other Mettler-Toledo International news, insider Christian Magloth sold 1,100 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $1,470.97, for a total transaction of $1,618,067.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at approximately $1,079,691.98. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $1,457.07, for a total transaction of $437,121.00. Following the completion of the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $7,160,041.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 1,100 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $1,470.97, for a total value of $1,618,067.00. Following the transaction, the insider now owns 734 shares in the company, valued at $1,079,691.98. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,278 shares of company stock valued at $4,871,849. Company insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

A number of large investors have recently bought and sold shares of MTD. Bank of New York Mellon Corp increased its holdings in shares of Mettler-Toledo International by 169.4% during the first quarter. Bank of New York Mellon Corp now owns 573,702 shares of the medical instruments supplier’s stock valued at $763,764,000 after acquiring an additional 360,786 shares in the last quarter. Norges Bank bought a new stake in Mettler-Toledo International during the 4th quarter valued at $320,847,000. Capital International Investors raised its holdings in Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after buying an additional 141,431 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Mettler-Toledo International by 65.4% in the fourth quarter. Principal Financial Group Inc. now owns 241,219 shares of the medical instruments supplier’s stock valued at $292,589,000 after buying an additional 95,421 shares in the last quarter. Finally, International Assets Investment Management LLC grew its holdings in shares of Mettler-Toledo International by 109,458.1% during the fourth quarter. International Assets Investment Management LLC now owns 67,926 shares of the medical instruments supplier’s stock valued at $82,392,000 after buying an additional 67,864 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.

Further Reading

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.